Enhanced External Counterpulsation (EECP) therapy is a non-invasive treatment that helps improve blood flow to the heart and relieve symptoms of angina and heart failure.

EECP therapy uses inflatable cuffs wrapped around the legs to compress and decompress the blood vessels, promoting increased blood flow to the heart during the relaxation phase of the heartbeat.

Patients with chronic stable angina, heart failure, or those who are not suitable candidates for invasive procedures like angioplasty or bypass surgery may benefit from EECP therapy.

EECP therapy can help reduce angina symptoms, improve exercise tolerance, enhance the quality of life, and decrease the need for medication in some patients.

Each EECP session typically lasts about one hour and is usually conducted five days a week for a total of seven weeks.

Symptoms may include confusion, fatigue, weakness, and in severe cases, coma.

Treatment involves reducing ammonia levels through medications and dietary changes.

Yes, certain medications, especially those metabolised by the liver, can influence ammonia levels.

Liver disease, kidney dysfunction, and urea cycle disorders can impact ammonia metabolism.

A blood sample is drawn from a vein in the arm and sent to a laboratory for analysis.

Chronic kidney disease is a long-term condition where the kidneys gradually lose function over time, leading to waste buildup in the body.

Common causes include diabetes, high blood pressure, glomerulonephritis, polycystic kidney disease, and recurrent kidney infections.

Symptoms may include fatigue, swelling in ankles and feet, nausea, shortness of breath, confusion, and decreased urine output.

Diagnosis is made through blood tests, urine tests, imaging studies, and sometimes a kidney biopsy to assess kidney function and damage.

Treatments include medications to manage symptoms, lifestyle changes, dialysis, and in severe cases, kidney transplantation.